Hege Kristen has filed 24 insider transactions across 3 companies since July 2023.
Most recent transaction: a disposition of 2088 shares of Mersana Therapeutics, Inc. ($MRSN) on January 06, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 6, 2026 | Mersana Therapeutics, Inc. | $MRSN | Hege Kristen | Director | D | Stock Option (right to buy) | 2088 | $0.00 | 0.0000 | 4,998,750 | 100.00% | 0.04% |
| Jan. 6, 2026 | Mersana Therapeutics, Inc. | $MRSN | Hege Kristen | Director | D | Stock Option (right to buy) | 138 | $0.00 | 0.0000 | 4,998,750 | 100.00% | 0.00% |
| Jan. 6, 2026 | Mersana Therapeutics, Inc. | $MRSN | Hege Kristen | Director | D | Stock Option (right to buy) | 734 | $0.00 | 0.0000 | 4,998,750 | 100.00% | 0.01% |
| Jan. 6, 2026 | Mersana Therapeutics, Inc. | $MRSN | Hege Kristen | Director | D | Stock Option (right to buy) | 146 | $0.00 | 0.0000 | 4,998,750 | 100.00% | 0.00% |
| Jan. 6, 2026 | Mersana Therapeutics, Inc. | $MRSN | Hege Kristen | Director | D | Stock Option (right to buy) | 380 | $0.00 | 0.0000 | 4,998,750 | 100.00% | 0.01% |
| Jan. 6, 2026 | Mersana Therapeutics, Inc. | $MRSN | Hege Kristen | Director | D | Stock Option (right to buy) | 257 | $0.00 | 0.0000 | 4,998,750 | 100.00% | 0.01% |
| Jan. 6, 2026 | Mersana Therapeutics, Inc. | $MRSN | Hege Kristen | Director | D | Stock Option (right to buy) | 2200 | $0.00 | 0.0000 | 4,998,750 | 100.00% | 0.04% |
| Jan. 6, 2026 | Mersana Therapeutics, Inc. | $MRSN | Hege Kristen | Director | U | Common Stock | 578 | $0.00 | 0.0000 | 4,998,750 | 100.00% | 0.01% |
| Jan. 6, 2026 | Mersana Therapeutics, Inc. | $MRSN | Hege Kristen | Director | D | Stock Option (right to buy) | 2460 | $0.00 | 0.0000 | 4,998,750 | 100.00% | 0.05% |
| Jan. 6, 2026 | Mersana Therapeutics, Inc. | $MRSN | Hege Kristen | Director | D | Stock Option (right to buy) | 142 | $0.00 | 0.0000 | 4,998,750 | 100.00% | 0.00% |
| Jan. 6, 2026 | Mersana Therapeutics, Inc. | $MRSN | Hege Kristen | Director | D | Stock Option (right to buy) | 400 | $0.00 | 0.0000 | 4,998,750 | 100.00% | 0.01% |
| Jan. 6, 2026 | Mersana Therapeutics, Inc. | $MRSN | Hege Kristen | Director | D | Stock Option (right to buy) | 1000 | $0.00 | 0.0000 | 4,998,750 | 100.00% | 0.02% |
| Jan. 6, 2026 | Mersana Therapeutics, Inc. | $MRSN | Hege Kristen | Director | D | Stock Option (right to buy) | 450 | $0.00 | 0.0000 | 4,998,750 | 100.00% | 0.01% |
| Jan. 6, 2026 | Mersana Therapeutics, Inc. | $MRSN | Hege Kristen | Director | D | Stock Option (right to buy) | 368 | $0.00 | 0.0000 | 4,998,750 | 100.00% | 0.01% |
| Jan. 6, 2026 | Mersana Therapeutics, Inc. | $MRSN | Hege Kristen | Director | D | Stock Option (right to buy) | 101 | $0.00 | 0.0000 | 4,998,750 | 100.00% | 0.00% |
| Jan. 6, 2026 | Mersana Therapeutics, Inc. | $MRSN | Hege Kristen | Director | D | Stock Option (right to buy) | 1002 | $0.00 | 0.0000 | 4,998,750 | 100.00% | 0.02% |
| Jan. 6, 2026 | Mersana Therapeutics, Inc. | $MRSN | Hege Kristen | Director | D | Stock Option (right to buy) | 416 | $0.00 | 0.0000 | 4,998,750 | 100.00% | 0.01% |
| Jan. 6, 2026 | Mersana Therapeutics, Inc. | $MRSN | Hege Kristen | Director | D | Stock Option (right to buy) | 1800 | $0.00 | 0.0000 | 4,998,750 | 100.00% | 0.04% |
| June 12, 2025 | Mersana Therapeutics, Inc. | $MRSN | Hege Kristen | Director | A | Stock Option (right to buy) | 61500 | $0.00 | 61,500.0000 | 124,631,339 | 9999.99% | 0.05% |
| July 1, 2024 | Adaptimmune Therapeutics PLC | $ADAPY | Hege Kristen | Director | A | Option to purchase Ordinary Shares | 660000 | $0.00 | 660,000.0000 | 1,559,183,774 | 9999.99% | 0.04% |
| June 11, 2024 | Mersana Therapeutics, Inc. | $MRSN | Hege Kristen | Director | A | Stock Option (right to buy) | 55000 | $0.00 | 55,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 15, 2024 | Adaptimmune Therapeutics PLC | $ADAPY | Hege Kristen | Director | A | Option to purchase Ordinary Shares | 81906 | $0.00 | 81,906.0000 | 1,206,440,978 | 9999.99% | 0.01% |
| Jan. 2, 2024 | Mersana Therapeutics, Inc. | $MRSN | Hege Kristen | Director | A | Stock Option (right to buy) | 6447 | $0.00 | 6,447.0000 | 0 | 9999.99% | 0.00% |
| July 19, 2023 | LENZ Therapeutics, Inc. | $LENZ | Hege Kristen | Director | A | Stock Option (right to buy) | 20000 | $0.00 | 20,000.0000 | 0 | 9999.99% | 0.00% |